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was 96.2%. AS was determined by a positive response to any of: have you I) been 
woken by an attack of shortness of breath at any time 2) had an attack of asthma 3) 
are you currently taking any medicine for asthma 4) had wheezing or whistling in 
your chest when you did not have a cold. R was determined by positive response 
to do you have any nasal allergies including hay fever. Symptoms prevalence 
was for woken by shortness of breath 19.2%, attack of asthma 0.9%, wheezing 
6.8%, asthma medication 0.9%, nasal allergies 20.5%. Overall AS prevalence was 
22.6% in the study population. This symptomatic group is currently undergoing 
the second stage of the study involving a detailed questionnaire, spirometry and 
allergy testing.
This study was supported by ASTRA and Society for Pulmonary Diseases.
P2197
Comorbidity in Asthma and COPD in Dutch General Practice
D. Bijl, J. van der Velden. Netherlands Institute of Primary Health Care, Utrecht, 
the Netherlands
Aim o f the study. To describe comorbidity in asthmatic and COPD-patients in 
Dutch general practice.
Patients and methods, Secondary analysis of data from the Dutch National Survey 
of General Practice (1987-88), covering 161 Dutch GPs with a total list size of 
335.000 patients. Comorbidity was defined as diseases or problems, that according 
to the GP, had a direct relation to the reason for encounter or the diagnosis. 
Comorbidity was registered as underlying diseases in the National Survey.
Results. GPs registered 3351 episodes of asthma (n = 1276) and COPD (n ~ 
2075) in patients 12 years and older. In these 3351 episodes 713 (= 21.3%) 
underlying diseases were registered. Significantly more underlying diseases were 
registered in asthma (216 = 16.9%) than in COPD (497 = 23.9%) (chi-square p =
0.03). Hypertension (p = 0.048), chronic heart failure (p = 0.006) and peripheral 
vascular disease (p = 0.006) were significantly more often registered in COPD 
than in asthma. Furthermore, diabetes, CVA, relationship problems and addiction 
problems were quite often registered as underlying disease. Compared to all co­
morbidity registered in the National Survey comorbidity in asthma and COPD is 
more prevalent,
Conclusion. Comorbidity is quite prevalent in asthma and COPD. It results in 
additional health problems, mainly in the field of cardio/cerebro-vascular diseases. 
In relation to the quality of care of asthma and COPD and the development of 
guidelines attention to comorbidity is necessary.
11 ] Bijl D, Dekkcr FW and Van der Velden J. Quality of care of asthma and COPD in Dutch Gen­
era! Practice. Eur Resp J 1994; 7 (s. 18):417s.
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Bronchial Asthma Symptoms in the Patients with Chronic Bronchitis 
T.N. Bilitchenko, Y.S. Lebed in, G.L. Osipova. Scientific Institute of Pulmonology, 
Moscow, Russia
it is difficult enough to distinguish the patients with bronchial asthma (BA) if they 
suffer from chronic bronchitis (CB). Randomized city population study including 
the sample of 706 subjects of both sexes (252 males and 454 females), aged 25-64 
permitted to analyse the serum IgE levels in relation to the presence or the absence 
of bronchial asthma symptoms. 1UATLD Questionnaire was used, The criterium of 
CB was generally accepted; BA criterium was the following: two positive answers 
about an attack of shortness of breath plus an attack of coughing or wheezing in 
the last 12 months. It was analysed logarithmic values of serum IgE. The patients 
were consulted by two doctors independently.
BA was found in 23.4% of the patients with CB and in 2.0% of the subjects 
without cough and sputum (p < 0.05). The geometrical mean of serum IgE was 
3.4 + 1,6 lU/ml in the patients with, chronic bronchitis and 4,6 + 1.6 IU/ml in the 
subjects with bronchial asthma (p = 0.01). In the patients with CB and coughing 
plus wheezing in the last 12 months IgE level was found lower: 4,3 + 1.8 IU/ml (p 
= 0.05). According to clinical study the specificity of BA criterium was 93% and 
sensitivity was 73%. Prognostic value was calculated as 69%.
Presented data allow to conclude that the criterium of BA may be very helpful in 
epidemiological and clinical study to recognize the patients with bronchial asthma.
P2199
Epidemiology of Nocturnal Asthma in a Rural Community of Northern Sicily
V. Bellia, R. Pistelli, G. Filippazzo, I. Cocilovo, F. Cibella, G. Cuttitta, G. Valenti, 
G. Bonsignore. istituto dl Pneumologla delVUmversita and Osservatorb 
Epidemiologico Regionale, Palermo, Italy
Nocturnal asthma (NA) is estimated to occur in 2/3 to 3/4 of patients; however 
there may be a gross overestimation: in fact available prevalence data do not 
pertain to the general population of asthmatics since derived from hospital series 
(Turner-Warwick, 1984) or from patients preselected because of active disease 
under treatment (Turner-Warwick, 1988), Therefore we evaluated the prevalence 
of NA-associated symptoms from data relevant to a prevalence study on asthma 
cases (AC, detected by doctor’s diagnosis and/or symptoms in the last 12 months), 
carried out on a general population sample (GPS) (n: 1100), randomly selected 
in a rural area of northern Sicily. To questions on frequent awakenings due to 
dyspnea or cough, a positive response was recorded respectively in 10 and 15% 
of asthmatics, as compared to L0 and 1.5% of GPS. Similarly 5 and 8.3% of 
asthmatics (0.9 and 1.6% of GPS), gave a positive response to questions on fre­
quent occurrence of breathlessness or chest tightness at wake-up in the morning.
Occasional occurrence of the cited symptoms was recorded in 16.7 to 23.3% of 
asthmatics and in 2,3 to 4.9% of GPS. These rates increased in subjects aged 
over 65 yrs (occasional report in 26.7 to 46.7%), although a confounding effect 
of cardiovascular diseases may be important. These data confirm that NA is “a 
manifestation of more severe inflammation in the airways of subjects with asthma" 
(Oosterhoff et AL., 1995) and as such it recurs in a percentage of patients much 
lower than previously estimated.
P2200
Single Breath Transfer Factor for Carbon Monoxide in Patients with 
Bronchial Asthma and Cold of a Norwegian Community Sample
I. Welle, P.S. Bakke, A. Gulsvik. Department o f Thoracic Medicine, University of 
Bergen, Bergen, Norway
Limited community based data is available on the distribution of transfer factor 
variables in healthy and diseased subjects in Northern Europe. In a cross sectional 
survey of a Norwegian general population sample of 1275 subjects aged 18-73 
years examination with single breath transfer factor for carbon monoxide (TLCO) 
was performed. The subjects also were diagnosed as having bronchial asthma 
or chronic obstructive lung disease (COLD) based on a clinical and spirometric 
examination (Thorax 1991;46:863-70). The prevalences of bronchial asthma and 
COLD in this population were 2.4% and 5.4%, respectively, Reference values for 
TLCO were estimated from never-smoking subjects of the present sample without 
respiratory symptoms or disorders (Thorax 1992;47:167-73). When these reference 
values were applied on the entire sample mean (SD) TLCO in percent predicted 
(TLCO%) in patients with bronchial asthma were 97% (13%) in men and 106% 
(15%) in women. Corresponding figures In patients with COLD were 82% (25%) 
in men and 90% (19%) in women, while in subjects with neither of the disorders 
the figures were 101% (15%) and 102% (14%). In conclusion, in this Norwegian 
community sample patients with COLD had reduced values of TLCO%, while 
patients with bronchial asthma had normal values of TLCO%. For both asthmatics 
and COLD patients men tended to have lower values of TLCO% than women.
P2201
The Importance of Asthma Education in Patients with Asthma
E. Akkaya, A. Yilmaz, A. Baran, R. Baran, Z. Kili«;, T. §adoglu. Siireyyapa$a 
Center for Chest Diseases and Thoracic Sttrgety, Istanbul- Turkey
Despite recent developments in the diagnosis and treatment of asthma, there seems 
to be rise in morbidity and mortality related to inadequate education of patients 
lacking necessary information about the disease. This study sought to evaluate 
patients’ information about their disease and their metered-dose inhaler (MDJ) use 
in two groups of patients. Group I consisted of 22 patients who had been receiving 
treatment at our Allergy and Asthma Center, and Group II involved 2 1 patients who 
sought treatment for the first time. All the patients (16 males, 27 females, mean 
age 28.1 years, range 10-49 years) were randomly selected from their respective 
groups. Initially the patients were asked to fill a questionnaire. Their MDI uses 
were scored by a vitalograph and an observer. Educational seminars o f six sessions 
were held. The questionnaire and the monitored MDI use were repeated two times, 
one after two months and the other after a year. The results were as follows:
Before education End of 2nd month End of ¿i year
Group I (KS%)* 38.5 ±14.26 87.16± 10.51 94.7 ± 5.36
Group II (KS%) 20.72*17.11 87.11 ±9,95 94.73 ± 5 .15
Proper MDI use 16/43 (37.2%) 31/43 (72.09%) 33/39 (84.6%)
Observer and
vitaiogaipli tigt'csmcni 31/43 (11%) 38/43 (88%) 39/39 (84.6%)
!|!KS-knowlcdgc score
This study helped reveal that patients do not have sufficient information about their 
disease and the use of MDIs, and that education and training can play a significant 
role in the disease morbidity and mortality.
P2202
Detection of Adult Asthma/COPD in General Practicc
G. van den Boom ,,2;C.P. van Schayck *, M.P.M.H. Rutten2, P.R.S. Tirimanna1,
1 Dept General Practice and Social Medicine, University of Nijmegen; 2 Dept 
Health Economics, University of Limburg, The Netherlands
In 10 general practices, a large sample (n — 1155) of the open adult population has 
been screened for (early) signs of asthma/COPD. Non steroid-dependent subjects 
with ages between 25 and 70 were included. Screening consisted of lung function 
, measurements (FEVj, VC and reversibility after 0,8 mg salbutamol) and a Dutch 
version of the MRC questionnaire, A mildly impaired lung function, the presence 
of symptoms or a combination of both rendered a positive screening result: these 
subjects were regarded as having an increased risk of developing asthma/COPD 
or were likely to have as yet undetected asthma/COPD. In this sample 51% (n = 
601) had a positive screening result. These subjects were being monitored every 
3 months to accurately detect subjects with as yet undetected asthma/COPD and 
subjects with a rapid decline in lung function. Undetected asthma/COPD was 
defined as:
at least 2 out of 4 periodical measurements: FEVj < pred -  2 sd or 
PC20 < 2 mg histamine/ml and FEVj , reversibility > 15% of pred.
A rapid decline in lung function was defined as:
355s
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decline in FEVj > 80 ml/year (linear regression) and
P C < 8 mg histamine/m) and/or FEVj reversibility > 10% of pred.
A total of 384 subjects were willing to participate in the monitoring phase. 
I4c/c (n = 54) of subjects with a positive screening result had as yet undetected 
asthma/COPD. In the remaining 330 subjects, 24% (n =  80) displayed a rapid 
decline in lung function. Throughout the study, there were no indications of 
recruitment or selection bias (tested statistically). More than 70% of subjects 
with undetected astlima/COPD and subjects with a rapid decline in lung function 
had never ever visited their general practitioner or pulmonologist for respiratory 
complaints before.
Conclusion: Generalizing our findings to the general population in our region, 
we observe that approximately 7% of the general population may be regarded 
as having as yet undetected asthma/COPD. In approximately 10% of the general 
population, a rapid decline in lung function can be seen.
P2203
Rates of Admission to University Hospital for Asthma
V. Petrovic, Lj. Nagomi, M. Vukcevic, B, Gvozdenovic. institute for Pulmonary
Diseases, Clinical Center o f Serbia, Yugoslavia
There has been considerable interest in hospital admissions attributed to asthma 
over past decades. The aim of this study was to describe trends in asthma hospital­
ization to University hospital which is referral center for respiratory diseases. We 
analyzed 1696 pis records with first discharge diagnosis (1CD 9, code 493) from 
1988 to 1995. Time trends were calculated as percentage using the 1988 admission 







Increasing % of 
admissions related 
to 1988 year
1988 115 5564 2.1
1980 [40 5702 2.5 > 21.7
1990 182 6032 3.0 > 58.3
1991 209 5832 3.6 > 81,7
1992 310 5892 5.3 > 169.6
J993 306 5962 5.1 > 166,0
1994 200 5453 3.7 > 73.9
1995 234 4592 5.1 > 103.5
Total . 1696 45029 X = 3.8
Distinct seasonal fluctuation was noticed. For each of the years 1988 until 1995 
a large autumnal increase in asthma admission occurred. The overall largest peak 
was in September-October when 343 pts (20%) from the whole group were hospi­
talized. A smaller peak occurred each year in January-February 302 pts (17.7%). 
Seasonal pattern of status asthmaticus admissions was similar. During 8 yrs 165 
pts (9.7%) had status asthmaticus, 41 pts (24.8%) in January-February and 39 pts 
(23.6%) in September-October. Due to asthma 19 pts (i.1%) died. Annual death 
rate was one to five. Eight asthma deaths (42%) occurred in May and June. In 
conclusion: admission rates attributed to asthma showed upward trend through 
examined period for all ages and both sexes. Apparently steeper increase was until 
1991 and than dramatically increased in 1992 and 1993. The observed increase 
may reflect actual increase in prevalence or severity of asthma, a change in di­
agnoses, therapeutic or nosologic practices. Seeking to explain dramatic increase 
we considered change in medical care leading to a shift of asthma patinets from 
the community to hospital setting because of the shortness of anti asthma drugs 
during the two years of isolation of Yugoslavia.
P2204
+Labelling Shift from Bronchitis to Asthma: A Contributing Factor to the 
Rise in Asthma M ortality in Rio G rande Do Sul, Brazil?
J.M. Chatkin1, M.W. Gerbase 1, C.C. F r i t s che r C. M.  A b r e u L . O .  Bridi *, 
N.A. Fonseca1, Barreto S.S. M enna2. 1 School o f Medicine, Pontificia 
Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil; 2 School of 
Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
An important rise in asthma mortality rates in the group aged 5 to 39 years old 
was recently demonstrated in the State o f Rio Grande do Sul, Brazil. In order to 
evaluate this observation we compared three groups of death certificates: 1) all 
deaths due to obstructive diseases (ICD9 490, 491, 492, 493, 466 and 496), 2) 
those due to asthma (ICD9 493), and 3) all obstructive diseases excluding asthma, 
during the period 1970 to 1993. Using the least square method and the linear 
regression procedures, the annual variation of the mortality rates was calculated. 
Results showed that when all obstructive diseases were examined together the 
average annual increase of the rates was 0,0101 f 0,0176 and 0,0176 respectively in 
the age groups 5-19, 20-39 and 5-39. When asthma was studied isolatedly in the 
same age groups also positive trends were observed (0.0088, 0.0012 and 0.0067, 
respectively in the same age groups 5-19, 20-39 and 5-39). However, the trends 
related to obstructive diseases excluding asthma registered a decreasing annual 
average of 0,0035,0.014 and 0.0077 for the same age groups. Our data corroborate 
the suggestion found in the international literature that perhaps the rise in asthma 
mortality could be due to a shift on the diagnosis of the causa mortis to asthma. 
So, one o f the factors contributing to the enhanced mortality in asthma found in 
the State of Rio Grande do Sul, Brazil could be the incorrect filling of the death 
certificates.
P2205
Hay Fever and Asthma in an Urban Community in Norway
C. Svanes, E. Omenaas, 0 . Fluge, A. Gulsvik. Department o f Thoracic Medic i n
University of Bergen, Norway
The association between asthma and hay fever is well known and may be relat« 
to common allergic disposition» We present results from a population-based surv< 
in Norway 199J-J993, where a random sample of 4300 persons in the age g r o i  
20-44 years, of whom 80% responded, was investigated. Asthma symptoms, b -  
fever and possible confounding factors were recorded. The association betwe< 
hay fever and asthma symptoms (last 12 months) was studied by logistic regressi< 
analyses, while adjusting for differences in smoking habits, hospitalisation for Iuj  
disease in early childhood, age, sex and bodymass.
Hay fever was reported in 19% of the population (men: 18%, women: 20%). T  
prevalence decreased with age, and was higher among non-smokers. A s th m a  
attacks and use of asthma medicine was eight-fold higher in persons with hay f e \  
(asthmatic attacks: OR « 8.4,95% C! 5.5-12.9; use of asthma medicine: OR =  7  
95% Cl 5.0-11.5), while less specific symptoms of asthma was more m oderate 
associated with hay fever (night dyspnea: OR =* 3.8, 95% Ci 2.7-5.4; monrvi 
dyspnea: OR = 2 .7 ,95% CI 2,1-3.4; wheezing: OR = 2 .1, 95% CI 1.7-2.5; n i£  
cough: OR = 1.4, 95% CI l.i-1,7).
Conclusion An association between asthma and hay fever was confirmed. H  
fever was more strongly related to a physician’s diagnosis of asthma than to a i r w  
symptoms.
P2206
Is the Practice Ratio of Inhaled Corticostcroid: Bronchodilator A ssociated 
with Asthma Morbidity in Deprived Areas?
M. Shelley1, P, Croft1, S. Chapman 2, C. Pantin *. 1 Industrial and Community 
Health Research Centre, School o f Postgraduate Medicine, North Staffordshire 
Medical Institute, Hartshill Road, Stoke-on-Trent, ST4 7NY, UK; - Department 
Pharmacy Policy and Practice, Keele University, Staffordshire, ST5 5BG, UK
Previous work has shown family practices located in deprived areas with Io a  
practice ratios of inhaled corticosteriod:bronchodiIator (C:B) had higher h o s p  
admission rates for asthma. A symptom based postal questionnaire was u s e d  
ascertain a more detailed morbidity profile of asthma patients in two p ractfc  
One practice had a high C:B ratio (1.53) and the other a low C:B ratio (0*2 
Both practices were located in deprived areas. All patients who had r e c e r  
a prescription for an anti-asthma drug over the past 18 months were s e n t  
questionnaire (n -  179 for practice with high C:B and n *= 187 for practice v  
low C:B). The unadjusted response rate to the questionnaire was 86% and 7 1  
There was a significant difference between the practices in self-reported a s th  
symptoms for both the 5-44 age group (P < 0.0000; n = 60 and 75) and for t h  
with a family practitioner’s diagnosis of asthma (P < 0.0000; n = 70 and i 
There was no significant difference in age/sex profiles, social class or sm o l; 
habits between the practices for either the 5-44 age group or the diagnosed a s t l  
group. A family practice with a low practice C:B ratio had significantly g r e  
asthma morbidity compared to a practice with a high practice C:B ratio, lo c a te ' 
a similarly deprived area.
CFTR — Prevalence, diagnostic features < 
respiratory involvement and clinical care < 
cystic fibrosis
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Epidemiology of Cystic Fibrosis in Russia
N,L Kapranov, J.K. Ginter, N.V. Petrova, N.J. Kashirskaya, O. Simonova,
L. Shabalova. Department of Cystic Fibrosis, Institute of Clinical Genetics, FL
Cystic Fibrosis (CF) is the commonest lethal recessive autosomal disease a n  
Caucasian populations. The frequency of CF and CFTR gene mutations (e sp e c  
of AF508 deletion) is variable in different countries. During last two y e a rs  
frequency of CF in Russian population has been studied. We found that CF a f  
1 in 12,000 new-boms. The major AF508 mutation was found in 58% ch r<  
somes of CF patients among Russian population and 41% chromosomes a n  





The most common mutations in Russian population were different to th o s i  
scribed in Europe. N1303K, 2143delT, 2I84insA, G542X, W1282X, 3732<
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